Healthcare Equipment and Supplies
Company Overview of American Medical Systems, LLC
American Medical Systems, LLC develops medical devices for the treatment of pelvic disorders. The company offers AdVance, a male sling system for the treatment of male stress urinary incontinence (SUI); AMS 700, an inflatable penile prosthesis device for infrapubic or penoscrotal approaches; AMS 800, a urinary control system that is used in the treatment for male SUI following the prostate surgery; AMS Ambicor, an inflatable penile prosthesis device that eliminates the need for separate reservoirs; Aura XP, a laser therapy system for a range of soft tissue clinical applications; and Elevate, an anterior and apical prolapse repair system. It also offers Elevate, an apical and posterior prolap...
10700 Bren Road West
Minnetonka, MN 55343
Founded in 1972
Key Executives for American Medical Systems, LLC
Vice President of Finance
Senior Vice President and General Manager of Europe/Middle East & Africa Region
Senior Vice President of Global Procurement/ Manufacturing/ Distribution/ Quality/ Regulatory Affairs/ R&D
Compensation as of Fiscal Year 2016.
American Medical Systems, LLC Key Developments
Boston Scientific Reportedly Close To Acquiring Endo AMS
Feb 24 15
Boston Scientific Corporation (NYSE: BSX) is close to buying American Medical Systems, Inc. from Endo International PLC (NasdaqGS:ENDP). The deal will value the business at around $2 billion, according to people familiar with the matter. The companies are aiming to finalize an agreement within a matter of weeks, the people said this week, cautioning that discussions are continuing and could still fall apart. The sources asked not to be named because the matter is not public. Reuters added that a representative for Boston Scientific declined to comment. A representative for Endo could not be reached for comment.
American Medical Systems Inc. Announces Positive Top-Line Results from TRANSFORM Study
Sep 8 14
American Medical Systems Inc. announced positive top-line results from its TRANSFORM study. The results show that over a 12 month period, 69% of women suffering from fecal incontinence who were implanted with the TOPAS System experienced at least a 50% reduction in weekly incontinence episodes and experienced a durable, consistent effect across the study period. The results were presented in Cape Town, South Africa at the International Society of University Colon & Rectal Surgeon (ISUCRS) Congress. The TOPAS System is an innovative, minimally-invasive approach to treating fecal incontinence, also known as accidental bowel leakage, or ABL. It uses a permanent mesh implant that is designed to restore and maintain anatomic support of the pelvic floor muscles. TOPAS is in development for women with ABL who have failed conservative therapy, which includes dietary changes, anti-diarrheal medications or bulking agents and pelvic floor muscle training. This is an investigational device whose efficacy and safety are not yet approved by the U.S. Food and Drug Administration (FDA).
American Medical Reported Updates On Sale
Aug 25 14
American Medical Sytems, Inc. has been put up for sale by Endo International plc (NasdaqGS:ENDP) and private equity firms are among the prospective buyers courting it for as much as $2 billion, The Wall Street Journal reports, citing people familiar with the matter.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries